The MyLungHealth Study Protocol: Engaging Patients to Enable Interoperable Lung Cancer Decision Support at Scale
Early lung cancer screening (LCS) through low-dose computed tomography (LDCT) is crucial but underused due to various barriers, including incomplete or inaccurate patient smoking data in the electronic health record and limited time for shared decision-making. The objective of this trial is to investigate a patient-centered intervention, MyLungHealth, delivered through the patient portal. The intervention is designed to improve LCS rates through increased identification of eligible patients and informed decision making.
Checked against the public recordLast updated Mar 27, 2026 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Screening
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- University of Utah
- Interventions being studied
- Behavioral: MyLungHealth; Behavioral: DecisionPrecision+
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion criteria for both study 1 and study 2: * aged 50-79 * a history of smoking (e.g., current or former tobacco use) * seen in a study primary care clinic in the 12 months preceding the start of the trial Exclusion criteria for both study 1 and study 2: * \>0 but \< 10 pack-year smoking history or quit more than 15 years ago * No use of the patient portal at least once in the year preceding the start of the study * A lung cancer diagnosis at the start of the study * LDCT completed in the past 3 years * Another chest CT completed in the past year * Structured EHR data indicating LCS SDM was provided in the past 3 years * Exposed to the intervention during the pilot phase * No visit at a study clinic during the trial period when the intervention was available Inclusion criteria for study 1: * a 10-19 pack-year smoking history, an unknown pack-year history, unknown quit date for patients who quit smoking, or a 0 pack-year smoking history Inclusion criteria for study 2: * at least a 20 pack-year smoking history and are a current smoker or have quit within the last 15 years
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- NYU Langone HealthNew York, New York
- University of Utah HealthSalt Lake City, Utah
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Mar 27, 2026. Always confirm current availability with the study team.